AGIOS PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

AGIOS PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $89.13 million for the year ending 2025.

  • AGIOS PHARMACEUTICALS, INC. showed an increase of +16.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from AGIOS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), AGIOS PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 14.4%.
  • Historical annual values: Fiscal year 2025: $89.13 million | Fiscal year 2024: $76.25 million | Fiscal year 2023: $88.21 million | Fiscal year 2022: $139.26 million | Fiscal year 2021: $203.13 million | Fiscal year 2020: $127.44 million | Fiscal year 2019: $80.93 million | Fiscal year 2018: $70.50 million | Fiscal year 2017: $102.72 million | Fiscal year 2016: $160.75 million | Fiscal year 2015: $71.76 million | Fiscal year 2014: $14.03 million | Fiscal year 2013: $71.56 million | Fiscal year 2012: $91.30 million | Fiscal year 2011: $117.66 million | Fiscal year 2010: $77.88 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: